Resonate Blends (Resonate Blends) EBIT : $-0.78 Mil (TTM As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Resonate Blends EBIT?

Resonate Blends's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-0.08 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.78 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Resonate Blends's annualized ROC % for the quarter that ended in Dec. 2023 was -32.00%. Resonate Blends's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -148.66%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Resonate Blends's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -16.04%.

Resonate Blends EBIT Historical Data

The historical data trend for Resonate Blends's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonate Blends EBIT Chart

Resonate Blends Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-3.31

-1.85

-4.73

0.80

-0.78

Resonate Blends Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															-0.05	-0.34	-0.30	-0.07	-0.08

Competitive Comparison of Resonate Blends's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Resonate Blends's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resonate Blends's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Resonate Blends's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Resonate Blends's EV-to-EBIT falls into.

Resonate Blends EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.78 Mil.

Resonate Blends (OTCPK:KOAN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Resonate Blends's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-0.828 * ( 1 - 0% )	/	( (2.547	+	2.628)	/ 2 )
=	-0.828	/	2.5875
=	-32.00 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.959	-	0.431	-	( 0.001	-	max(0, 2.96	-	0.941	+	0.001	))
=	2.547

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.992	-	0.515	-	( 0.007	-	max(0, 3.128	-	0.977	+	0.007	))
=	2.628

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Resonate Blends's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.304	/	( ( (0.018 + max(0.088, 0))	+	(0.015 + max(0.288, 0)) )	/	2 )
=	-0.304	/	( ( 0.106	+	0.303 )	/	2 )
=	-0.304	/	0.2045
=	-148.66 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0.101	+	0.719)	-	(0.431	+	0	+	0.301)
=	0.088

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.97)	-	(0.515	+	0	+	0.167)
=	0.288

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Resonate Blends's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-0.78	/	4.863
	=	-16.04 %

Resonate Blends EBIT Related Terms

Thank you for viewing the detailed overview of Resonate Blends's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonate Blends (Resonate Blends) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Resonate Blends Inc (OTCPK:KOAN) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

26565 Agoura Road, Suite 200, Calabasas, CA, USA, 91302

Website

https://www.resonateblends.com

Resonate Blends Inc is a cannabis/hemp-based holding company. It is focused on a vertically integrated and valued-added Wellness and Lifestyle brand.

Executives

Richard Hoge	10 percent owner	C/O JIM KEARNEY, 760 SW 9TH AVE. STE 3000, PORTLAND OR 97205
Pamela Kerwin	officer: Chief Operating Officer	26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
Geoffrey Selzer	director, officer: Chief Executive Officer	26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
David Thomas Thielen	10 percent owner, officer: COO	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Nick Allen Miniello	10 percent owner, officer: VP of Sales	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Wais Asefi	director, 10 percent owner, officer: CEO	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Sterling John M Iii	director
Gregory Oliver Sargent	10 percent owner	1609 FAIRFIELD BEACH ROAD, FAIRFIELD CT 06824
Steven Richard Deerwester	officer: Vice President	3125 DARTMOUTH PLACE, CUMMING GA 30041
David G Kane	other: Controller	50 JOE LEE DRIVE, SHARPSBURG GA 30277
I Sigmund Mosley	director	945 E PACES FERRY RD, SUITE 2450, ATLANTA GA 30326
Vincent J Dooley	director	2859 PACES FERRY ROAD, SUITE 1000, ATLANTA GA 30339
Spencer John N Jr	director	2859 PACES FERRY RD, STE 1000, ATLANTA GA 30339
Marsha K Calfee	officer: VP of Product Development
Jeffrey Longoria	officer: VP of Sales